TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia.

Sponsor
Bournemouth University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04964635
Collaborator
Salisbury NHS Foundation Trust (Other)
10
1
24.2
0.4

Study Details

Study Description

Brief Summary

Functional Electrical Stimulation is an established technique in which small electrical impulses are used to cause a contraction in muscles and thereby enable movement, in people with neurological or musculoskeletal problems who are unable to undertake those movements themselves. People with spinal cord injuries of the neck at C5, C6 and C7 account for 35% of all spinal cord injuries. Despite this, there is only one commercial FES (Functional Electrical Stimulation) based orthosis currently available. Even that has limitations in that it as it has a single size rigid exoskeleton it does not fit all people who could benefit and also due to its rigidity it does not allow people with lower injuries to utilise any remaining tenodesis grip. As a result, it is not widely used within the spinal injured communities. Therefore what is required is a more flexible system that can benefit a larger number of people whilst still being affordable within the constraints of the NHS. A previous INSPIRE funded project, TETRAGRIP I demonstrated that a surface FES system controlled by an inertial sensor, measuring movement of the opposite shoulder, could meet this specification and was successfully tried on two people with tetraplegia. What is now required is a more detailed study in which the principle components of that system are incorporated into a practical device suitable for use at home without clinical supervision. It is therefore proposed to develop and build such a system and to conduct extended home based trials in three people with tetraplegia.

Condition or Disease Intervention/Treatment Phase
  • Device: TetraGrip II system
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia.
Actual Study Start Date :
Oct 26, 2021
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Grasp Release Test (GRT) [Start of study - 30 minutes building up to 60 minutes over a four week period]

    Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period

  2. Grasp Release Test (GRT) [At the end of the clinical phase (week 10) - 30 minutes building up to 60 minutes over a four week period]

    Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period

  3. Grasp Release Test (GRT) [At the end of the home phase for participants taking the device home (week 18) - 30 minutes building up to 60 minutes over a four week period]

    Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period

Secondary Outcome Measures

  1. Measurement of palmar grip [At the start of the study - 30 minutes]

    Test to be completed both with and without the device

  2. Measurement of pinch grip [At the start of the study - 30 minutes]

    Test to be completed both with and without the device

  3. Measurement of palmar grip [At the end of the clinical phase (week 10) - 30 minutes]

    Test to be completed both with and without the device

  4. Measurement of pinch grip [At the end of the clinical phase (week 10) - 30 minutes]

    Test to be completed both with and without the device

  5. Measurement of palmar grip [At the end of the home phase for participants taking the device home (week 18) - 30 minutes]

    Test to be completed both with and without the device

  6. Measurement of pinch grip [At the end of the home phase for participants taking the device home (week 18) - 30 minutes]

    Test to be completed both with and without the device

Other Outcome Measures

  1. Two Point Discrimination Test [At the start of the study]

    Test to be completed both with and without the device

  2. Two Point Discrimination Test [At the end of the clinical phase (week 10)]

    Test to be completed both with and without the device

  3. Two Point Discrimination Test [At the end of the home phase for participants taking the device home (week 18)]

    Test to be completed both with and without the device

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Have a spinal cord injury that has resulted in tetraplegia affecting hand function.

  • Minimal spasticity of wrist muscle.

  • Able to do shoulder elevation.

  • Upper limb passive range of motion should be within normal limit.

  • Age group: 18 years and above.

  • Able to understand and comply with assessment procedures.

  • Able to give informed consent.

  • Able to produce a muscle contraction using electrical stimulation in sufficient muscles produce a functional grip.

Exclusion Criteria:
  • Using a cardiac pacemaker, defibrillator or other sensitive implanted device.

  • Pregnant or planning to become pregnant over the course of the study.

  • A history of poorly controlled epilepsy.

  • If there is malignancy on the hand or arm.

  • If younger than 18

  • Severe contracture of wrist and finger joints.

  • Painful shoulder.

  • Suffering from significant autonomic dysreflexia in response to FES.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Salisbury District Hospital Salisbury Wiltshire United Kingdom SP2 8BJ

Sponsors and Collaborators

  • Bournemouth University
  • Salisbury NHS Foundation Trust

Investigators

  • Study Director: Ian Swain, Professor, Professor in Technology & Design
  • Principal Investigator: Paul Taylor, Professor, Consultant Clinical Scientist - Salisbury District Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bournemouth University
ClinicalTrials.gov Identifier:
NCT04964635
Other Study ID Numbers:
  • RED 10356
First Posted:
Jul 16, 2021
Last Update Posted:
Nov 4, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 4, 2021